Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. May 27, 2022; 14(5): 525-527
Published online May 27, 2022. doi: 10.4240/wjgs.v14.i5.525
Published online May 27, 2022. doi: 10.4240/wjgs.v14.i5.525
Providing higher value care for hepatocellular carcinoma rather than diagnosis: What can current radiologists do?
Shan Yao, Yi Wei, Bin Song, Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Yao S and Song B designed the research; Yao S and Wei Y conducted literature search and analysis; Yao S wrote the letter and made critical revisions to the letter; Song B and Wei Y provided material and funding support for the article.
Supported by the Science and Technology Support Program of Sichuan Province , No. 2021YFS0144 and No. 2021YFS0021 ; and China Postdoctoral Science Foundation , No. 2021M692289 .
Conflict-of-interest statement: All authors declared no potential conflict of interests related to this publication.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bin Song, MD, PhD, Chief Doctor, Director, Professor, Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu 610041, Sichuan Province, China. cjr.songbin@vip.163.com
Received: January 6, 2022
Peer-review started: January 6, 2022
First decision: March 12, 2022
Revised: March 16, 2022
Accepted: May 13, 2022
Article in press: May 13, 2022
Published online: May 27, 2022
Processing time: 138 Days and 13.7 Hours
Peer-review started: January 6, 2022
First decision: March 12, 2022
Revised: March 16, 2022
Accepted: May 13, 2022
Article in press: May 13, 2022
Published online: May 27, 2022
Processing time: 138 Days and 13.7 Hours
Core Tip
Core Tip: Medical imaging plays a vital role in the accurate diagnosis and grading of hepatocellular carcinoma as clinical treatment decision-making. Moreover, it is of powerful value for noninvasively preoperative evaluation of the treatment outcomes, prognosis, and survival with high sensitivity and repeatability. The comprehensive assessment involving preoperative, perioperative, and postoperative indicators for treatment option selection will assist surgeons precisely and maximize the benefits for patients.